Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
- 1 June 1996
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (6) , 848-854
- https://doi.org/10.1016/s0272-6386(96)90523-5
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Lipoprotein(a) Levels and Fibrinolytic Activity in Patients with Nephrotic SyndromeNephron, 1995
- An overview of regular dialysis treatment in Japan (as of Dec. 31, 1992).Nihon Toseki Igakkai Zasshi, 1994
- Cholesterol and lipoproteins: Beyond atherogenesisClinical Cardiology, 1992
- Coronary artery disease and factor VII hyperactivity in elderly JapaneseThe American Journal of Cardiology, 1992
- Elevation of factor VII activity and mass in coronary artery disease of varying severityClinical Cardiology, 1991
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986
- Serum Lipids and Lipoproteins during Continuous Ambulatory Peritoneal DialysisActa Medica Scandinavica, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Lipid abnormalities in uremia, dialysis, and transplantationKidney International, 1981